706 results on '"Gilkeson, Gary S"'
Search Results
2. Transancestral mapping and genetic load in systemic lupus erythematosus.
3. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases
4. Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus
5. Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression
6. Two Functional Lupus-Associated BLK Promoter Variants Control Cell-Type- and Developmental-Stage-Specific Transcription
7. Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry
8. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups
9. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus
10. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian–European populations
11. Evaluation of TRAF6 in a large multiancestral lupus cohort
12. 1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons
13. 902 Loss-of-function variants inSAT1cause X-linked Childhood-onset Systemic Lupus Erythematosus
14. Estrogen Receptor Alpha Modulates Mesangial Cell Responses to Toll-Like Receptor Ligands
15. Loss-of-function variants inSAT1cause X-linked childhood-onset systemic lupus erythematosus
16. A Targeted Inhibitor of the Complement Alternative Pathway Reduces RPE Injury and Angiogenesis in Models of Age-Related Macular Degeneration
17. Conditional knockout of oestrogen receptor alpha in CD11c + cells impacts female survival and inflammatory cytokine profile in murine lupus
18. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus
19. Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals
20. Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features
21. Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus
22. Humoral Response
23. Glomerular Binding Antibodies in Systemic Lupus Erythematosus
24. Complement-Targeted Therapies in Lupus
25. Safety, Immunologic Effects and Clinical Response in a Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells in Patients with Treatment Refractory Systemic Lupus Erythematosus
26. Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far
27. Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis
28. A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals
29. Up‐Regulated Interleukin‐10 Induced by E2F Transcription Factor 2– MicroRNA ‐17‐5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus
30. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy
31. List of Contributors
32. Reactive Nitrogen Intermediates in the Pathogenesis of Systemic Lupus Erythematosus
33. Identification of IRAK1 as a Risk Gene with Critical Role in the Pathogenesis of Systemic Lupus Erythematosus
34. Selective Cyclooxygenase-2 Inhibitor Suppresses Renal Thromboxane Production but Not Proliferative Lesions in the MRL/lpr Murine Model of Lupus Nephritis
35. 1506 A human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
36. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögrenʼs Syndrome
37. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA
38. Conditional knockout of oestrogen receptor alpha in CD11c+ cells impacts female survival and inflammatory cytokine profile in murine lupus.
39. Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
40. Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis
41. A Critical Role of the Transcription Factor Fli-1 in Murine Lupus Development by Regulation of Interleukin-6 Expression
42. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli‐1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells
43. Genetic landscape of Gullah African Americans
44. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes
45. Nitric Oxide Modulation of Redox-Modulated Cytokines in Lupus Nephritis: 61
46. The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy
47. Role for Msh5 in the regulation of Ig class switch recombination
48. Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic
49. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
50. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/Ipr mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.